An inter-laboratory validation of a real time PCR assay to measure host excretion of bacterial pathogens, particularly of Mycobacterium bovis

Advances in the diagnosis of Mycobacterium bovis infection in wildlife hosts may benefit the development of sustainable approaches to the management of bovine tuberculosis in cattle. In the present study, three laboratories from two different countries participated in a validation trial to evaluate the reliability and reproducibility of a real time PCR assay in the detection and quantification of M. bovis from environmental samples. The sample panels consisted of negative badger faeces spiked with a dilution series of M. bovis BCG Pasteur and of field samples of faeces from badgers of unknown infection status taken from badger latrines in areas with high and low incidence of bovine TB (bTB) in cattle. Samples were tested with a previously optimised methodology. The experimental design involved rigorous testing which highlighted a number of potential pitfalls in the analysis of environmental samples using real time PCR. Despite minor variation between operators and laboratories, the validation study demonstrated good concordance between the three laboratories: on the spiked panels, the test showed high levels of agreement in terms of positive/negative detection, with high specificity (100%) and high sensitivity (97%) at levels of 10(5) cells g(-1) and above. Quantitative analysis of the data revealed low variability in recovery of BCG cells between laboratories and operators. On the field samples, the test showed high reproducibility both in terms of positive/negative detection and in the number of cells detected, despite low numbers of samples identified as positive by any laboratory. Use of a parallel PCR inhibition control assay revealed negligible PCR-interfering chemicals co-extracted with the DNA. This is the first example of a multi-laboratory validation of a real time PCR assay for the detection of mycobacteria in environmental samples. Field studies are now required to determine how best to apply the assay for population-level bTB surveillance in wildlife.

Protection against Tuberculosis in Eurasian Wild Boar Vaccinated with Heat-Inactivated Mycobacterium bovis

Tuberculosis (TB) caused by Mycobacterium bovis and closely related members of the Mycobacterium tuberculosis complex continues to affect humans and animals worldwide and its control requires vaccination of wildlife reservoir species such as Eurasian wild boar (Sus scrofa). Vaccination efforts for TB control in wildlife have been based primarily on oral live BCG formulations. However, this is the first report of the use of oral inactivated vaccines for controlling TB in wildlife. In this study, four groups of 5 wild boar each were vaccinated with inactivated M. bovis by the oral and intramuscular routes, vaccinated with oral BCG or left unvaccinated as controls. All groups were later challenged with a field strain of M. bovis. The results of the IFN-gamma response, serum antibody levels, M. bovis culture, TB lesion scores, and the expression of C3 and MUT genes were compared between these four groups. The results suggested that vaccination with heat-inactivated M. bovis or BCG protect wild boar from TB. These results also encouraged testing combinations of BCG and inactivated M. bovis to vaccinate wild boar against TB. Vaccine formulations using heat-inactivated M. bovis for TB control in wildlife would have the advantage of being environmentally safe and more stable under field conditions when compared to live BCG vaccines. The antibody response and MUT expression levels can help differentiating between vaccinated and infected wild boar and as correlates of protective response in vaccinated animals. These results suggest that vaccine studies in free-living wild boar are now possible to reveal the full potential of protecting against TB using oral M. bovis inactivated and BCG vaccines

Efecto del tratamiento con bacilo de calmette-guérin sobre un modelo in vitro 3D de carcinoma escamoso de cabeza y cuello

Tesis inédita presentada en la Universidad Europea de Madrid. Facultad de Ciencias Biomédicas. Programa de Doctorado en Biomedicina y Ciencias de la Salud

Evaluación del desempeño de pruebas diagnósticas de tuberculosis en pacientes VIH positivo en dos hospitales públicos de Bogotá

La tuberculosis TB es una de las principales causas de muerte en el mundo en individuos con infección por VIH. En Colombia esta coinfección soporta una carga importante en la población general convirtiéndose en un problema de salud pública. En estos pacientes las pruebas diagnósticas tienen sensibilidad inferior y la enfermedad evoluciona con mayor frecuencia hacia formas diseminadas y rápidamente progresivas y su diagnóstico oportuno representa un reto en Salud. El objetivo de este proyecto es evaluar el desempeño de las pruebas diagnósticas convencionales y moleculares, para la detección de TB latente y activa pacientes con VIH, en dos hospitales públicos de Bogotá. Para TB latente se evaluó la concordancia entre las pruebas QuantiFERON-TB (QTF) y Tuberculina (PPD), sugiriendo superioridad del QTF sobre la PPD. Se evaluaron tres pruebas diagnósticas por su sensibilidad y especificidad, baciloscopia (BK), GenoType®MTBDR plus (Genotype) y PCR IS6110 teniendo como estándar de oro el cultivo. Los resultados de sensibilidad (S) y especificidad (E) de cada prueba con una prevalencia del 19,4 % de TB pulmonar y extrapulmonar en los pacientes que participaron del estudio fue: BK S: 64% E: 99,1%; Genotype S: 77,8% E: 94,5%; PCRIS6110 S: 73% E: 95,5%, de la misma forma se determinaron los valores predictivos positivos y negativos (VPP y VPN) BK: 88,9% y 94,8%, Genotype S: 77,8% E: 94,5%; PCRIS6110 S: 90% y 95,7%. Se concluyó bajo análisis de curva ROC que las pruebas muestran un rendimiento diagnóstico similar por separado en el diagnóstico de TB en pacientes con VIH, aumentando su rendimiento diagnostico cuando se combinan

The J1030 field: a new window on early large scale structures and faint radio-galaxy populations

The correlations between the evolution of the Super Massive Black Holes (SMBHs) and their host galaxies suggests that the SMBH accretion on sub-pc scales (active galactice nuclei, AGN) is linked to the building of the galaxy over kpc scales, through the so called AGN feedback. Most of the galaxy assembly occurs in overdense large scale structures (LSSs). AGN residing in powerful sources in LSSs, such as the proto-brightest cluster galaxies (BCGs), can affect the evolution of the surrounding intra-cluster medium (ICM) and nearby galaxies. Among distant AGN, high-redshift radio-galaxies (HzRGs) are found to be excellent BCG progenitor candidates. In this Thesis we analyze novel interferometric observations of the so-called "J1030" field centered around the z = 6.3 SDSS Quasar J1030+0524, carried out with the Atacama large (sub-)millimetre array (ALMA) and the Jansky very large array (JVLA). This field host a LSS assembling around a powerful HzRG at z = 1.7 that shows evidence of positive AGN feedback in heating the surrounding ICM and promoting star-formation in multiple galaxies at hundreds kpc distances. We report the detection of gas-rich members of the LSS, including the HzRG. We showed that the LSS is going to evolve into a local massive cluster and the HzRG is the proto-BCG. we unveiled signatures of the proto-BCG's interaction with the surrounding ICM, strengthening the positive AGN feedback scenario. From the JVLA observations of the "J1030" we extracted one of the deepest extra-galactic radio surveys to date (~12.5 uJy at 5 sigma). Exploiting the synergy with the X-ray deep survey (~500 ks) we investigated the relation of the X-ray/radio emission of a X-ray-selected sample, unveiling that the radio emission is powered by different processes (star-formation and AGN), and that AGN-driven sample is mostly composed by radio-quiet objects that display a significant X-ray/radio correlation.

Tuberculose

O vídeo apresenta a tuberculose como uma doença que afeta principalmente os pulmões, causada pelo bacilo de Koch. Informa sobre o histórico e estatística da doença no Brasil, os principais sintomas, suas formas de transmissão, os riscos para a doença, o tratamento diretamente observado, a saúde básica no Brasil (competências), as medidas de controle da doença, diagnóstico, formas clínicas de tuberculose, pesquisa de baciloscopia, exames de imagem, prova tuberculínica, interpretação de exames, tratamento, hospitalização e efeitos colaterais, além da informação sobre o fornecimento da vacina BCG, especialmente para as crianças.

Tuberculose

Tuberculose é uma doença infecciosa causada por bactérias que afetam principalmente os pulmões tendo como sintomas a febre, tosse seca e continua, cansaço, falta de apetite e suor excessivo. Sua transmissão ocorre pela inalação de gotículas contaminada pelo bacilo de kock ( tosse, fala, espirro). Cabe aos profissionais da Atenção Básica fazer o acompanhamento dos portadores de tuberculose dentro de sua areá de atuação, partindo da suspeita clínica, passando pelo encaminhamento para a investigação diagnóstica e acompanhamento dos casos confirmados. Realizando o controle diário, investigação e controle de contatos além de fornecer a vacinação BCG especialmente para as crianças.

Segunda opinião formativa: qual a conduta para um caso de contactantes domiciliares de um paciente que já está tratamento para hanseníase?

A Hanseníase é uma doença infecciosas crônica de importância para a saúde pública, tendo o Mycobacterium leprae como agente etiológico. O paciente que está sendo tratado deixa de transmitir a doença. É considerado contato intradomiciliar toda e qualquer pessoa que resida ou tenha residido com o doente de hanseníase nos últimos cinco anos.